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LC3-positive structures are 
prominent in autophagy-deficient 
cells
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David C. Rubinsztein1,2
Autophagy is an evolutionarily conserved process across eukaryotes that degrades cargoes like 
aggregate-prone proteins, pathogens, damaged organelles and macromolecules via delivery to 
lysosomes. The process involves the formation of double-membraned autophagosomes that engulf 
the cargoes destined for degradation, sometimes with the help of autophagy receptors like p62, which 
are themselves autophagy substrates. LC3-II, a standard marker for autophagosomes, is generated 
by the conjugation of cytosolic LC3-I to phosphatidylethanolamine (PE) on the surface of nascent 
autophagosomes. As LC3-II is relatively specifically associated with autophagosomes and autolysosomes 
(in the absence of conditions stimulating LC3-associated phagocytosis), quantification of LC3-positive 
puncta is considered as a gold-standard assay for assessing the numbers of autophagosomes in cells. 
Here we find that the endogenous LC3-positive puncta become larger in cells where autophagosome 
formation is abrogated, and are prominent even when LC3-II is not formed. This occurs even with 
transient and incomplete inhibition of autophagosome biogenesis. This phenomenon is due to LC3-I 
sequestration to p62 aggregates, which accumulate when autophagy is impaired. This observation 
questions the reliability of LC3-immunofluorescence assays in cells with compromised autophagy.
Autophagy is a process that has been widely implicated in the pathogenesis of various conditions, such as neu-
rodegenerative diseases, cancer, and inflammation. It targets substrates like long-lived proteins, aggregate-prone 
proteins, and damaged organelles for lysosomal degradation to maintain cellular homeostasis1,2. This process is 
conserved across eukaryotes and involves the formation of double-membraned structures known as autophago-
somes. The double-membraned autophagosomes form from cup-shaped structures known as phagophores and 
are responsible for the engulfment of cargoes that are subsequently degraded after fusion with lysosomes1.
Autophagosome formation involves two successive ubiquitin-like reactions. The first reaction employs the 
E1-like ATG7 and the E2-like ATG10 enzymes, which conjugate the ubiquitin-like ATG12 to ATG5. This conju-
gate then forms a complex with ATG16L13. The second set of reactions involves the ubiquitin-like LC3 protein 
family. LC3-I is generated by proteolytic cleavage of pro-LC3 by ATG4, which exposes a C-terminal glycine that is 
amenable to conjugation. ATG7, the E1-like enzyme, ATG3, an E2-like enzyme, and the ATG5-12-16L1 complex 
as the E3-like enzyme then conjugate LC3 family members to phosphatidylethanolamine (PE) on the surface of 
nascent autophagosomes1. The lipidated LC3, known as LC3-II, has a faster mobility than LC3-I on SDS PAGE 
and is relatively specifically associated with autophagosomes and autolysosomes (in the absence of conditions 
stimulating LC3-associated phagocytosis).
The autophagic system also harnesses proteins known as autophagy receptors, which increase the selectivity 
of the autophagic process by facilitating the engulfment of certain cargoes by the growing autophagosomes4. The 
autophagy receptor proteins share a common domain organisation containing both a ubiquitin-binding domain 
(UBD) and an LC3-interacting region (LIR)1,4, which allow them to act as bridging molecules recognising the 
degradation signal on the autophagic cargo on the one hand, and binding LC3 on the growing autophagosomal 
membrane on the other. The most widely studied autophagy receptor shown to play an important role in auto-
phagy is p62/SQSTM-1 (sequestosome-1)4,5. As these molecules are themselves autophagy substrates, their levels 
often increase when autophagy is perturbed5,6.
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Autophagosome numbers are widely assessed by quantifying LC3-II puncta numbers in cells using immu-
nocytochemistry/immunohistochemistry for endogenous LC3, or immunofluorescence for fluorescent-tagged 
LC37,8. These types of assays have been used for chemical and genetic screens and for assessing autophagy status 
both in cells and in vivo in different conditions. With such assays, the number or the overall area of LC3-positive 
structures can increase, if there is increased autophagosome formation or impaired degradation. However, it 
has been assumed that the numbers of LC3-positive structures and their area should decrease if autophago-
some biogenesis is impaired and that there should be no LC3-positive structures in cells where LC3-II cannot 
form. Surprisingly, we find that these assumptions are incorrect, as we show that LC3-I can be associated with 
p62-positive aggregates, which are known to accumulate and form inclusion bodies when autophagy is compro-
mised6,9. However, while the existing literature shows the formation of LC3-positive structures upon GFP-LC3 
overexpression in autophagy-null cells from mice (MEFs)9–12, we show that endogenous LC3-I in ATG9- and 
ATG16L1-knockout cells of human origin (HeLa cells) forms distinct ubiquitin-positive aggregates in associa-
tion with p62. More importantly, we show that this phenomenon occurs even under partial autophagy-deficient 
conditions after transient knockdown of essential autophagy genes, such as ATG7 and ATG10. The conditions of 
transient autophagy-deficiency in cells that occurs when using siRNA-mediated depletion also forms the under-
lying basis for many experimental strategies, such as drug screening assays in the field of autophagy. Therefore, 
these data have critical implications for interpreting one of the most widely used set of autophagy assays.
Results
Autophagy-deficient cells show aberrant LC3-positive puncta. While characterising ATG9 CRISPR 
knockout HeLa cells (Supp. Fig. 1a), we found that LC3-II levels were slightly reduced in these cells in normal 
conditions but were dramatically reduced compared to wild-type cells when cells were treated with bafilomycin 
A1 (a lysosomal inhibitor that blocks LC3-II degradation and thus allows one to infer LC3-II formation rates; 
Supp. Fig. 1b,c). This was associated with a clear increase in LC3-I in ATG9 knockout cells (Supp. Fig. 1b,d). 
These phenotypes were rescued when the ATG9 null cells were transfected with ATG9A-GFP (Supp. Fig. 1e,f). To 
confirm this observation, we used LC3 immunocytochemistry (Fig. 1a). Interestingly, the ATG9 knockout cells 
had fewer, but much larger LC3-positive structures, compared to control cells (Fig. 1b,c). This phenotype was also 
rescued by transfection of the ATG9-null cells with ATG9A-GFP (Fig. 1d–f and Supp. Fig. 1 g).
We next studied ATG16L1 knockout HeLa cells13 that have no LC3-II (Supp. Fig. 1h), as expected13. 
Surprisingly, these cells also had large LC3-positive structures, compared to control cells (Fig. 1g,h), a phenom-
enon seen with different antibodies and fixation protocols (Supp. Fig. 1i). LC3-positive structures become more 
prominent in control cells after treatment with lysosomal pH-modulating autophagy inhibitors that compromise 
autophagosome degradation, like bafilomycin A1 and ammonium chloride. However, lysosomal alkalinisation 
did not alter the LC3-positive structures in the ATG16L1-null cells (Fig. 1g,h).
To test whether the above observation could be replicated under conditions of acute autophagy knockdown 
in WT HeLa cells, we depleted ATG7 and ATG10 using siRNA-mediated knockdown (Fig. 2a). As expected, 
the LC3-II levels decreased upon ATG7 and ATG10 knockdown in the absence and presence of bafilomycin A1 
(Fig. 2b,c). However, the total number of LC3-positive structures and the total area of the LC3-positive structures 
increased after siRNA-mediated depletion of ATG7 and ATG10 (Fig. 2d–f). To ensure that the observed effect of 
ATG7 and ATG10 knockdown was not artefactual, we performed a rescue of the phenotype using overexpression 
of ATG7 and ATG10-FLAG constructs. Our results showed that the knockdown phenotype was rescued upon 
overexpression of ATG7 and ATG10 constructs (Supp Fig. 2a–f).
Non-conjugatable forms of LC3 form distinct LC3-I positive structures in autophagy-deficient 
cells. As ATG16L1-null cells form LC3-positive structures, we confirmed whether LC3-I is capable of forming 
distinct structures in cells using non-conjugatable forms of LC3 tagged with GFP at the N-terminus of the pro-
tein. The conjugation of LC3-I to phosphatidylethanolamine can be abolished by mutating glycine 120 to alanine 
(LC3-G120A) to abrogate the ubiquitin-like reaction14,15. LC3 with this mutation can exist as pro-LC3 and LC3-I 
forms in the cell. However, LC3-G120A-ΔC22, where the glycine 120 to alanine mutation is combined with dele-
tion of 22 amino acids located beyond the C-terminal alanine 120 residue (mimicking the ATG4 reaction), mim-
ics LC3-I15. Both of these mutants formed prominent structures in ATG9 null or ATG16L1 null cells (Fig. 3a–c 
and Supp. Fig. 3a), similar to wild-type GFP-LC3. Furthermore, overexpression of non-conjugatable mutant 
forms of other LC3-family members such as GFP-GABARAP-GA and GFP-GABARAP-L1-GA in ATG16L1 KO 
cells resulted in the formation of structures similar to the ones described above (Supp. Fig. 3b,c). These findings 
demonstrate the formation of LC3-positive puncta in autophagy-impaired cells, even under conditions where the 
process of LC3-lipidation is completely abrogated, and other members of LC3-family behave in a similar fashion 
under autophagy-impaired conditions.
The LC3-I positive structures are associated with p62 aggregates and are ubiquitin-positive. 
While these LC3-positive structures in ATG9-null and ATG16L1-null cells did not co-localise with a wide variety 
of endosomal (Fig. 3a,b, Supp. Fig. 4) and non-endosomal markers (Supp. Fig. 4), they appeared to co-localise 
perfectly with p62 (Fig. 4a and Supp. Fig. 4). Importantly, these p62 structures appeared to be ubiquitinated 
(Fig. 4b), suggesting that they represent p62 aggregates forming due to autophagy impairment6. Interestingly, 
since a recent study suggests that increased levels of LC3 inhibit the growth of p62 aggregates16, we therefore 
decided to further investigate the association of LC3 with p62. Super-Resolution Structured Illumination micros-
copy (SR-SIM) showed a clear association between LC3 and p62 structures (Fig. 5a–c). These p62 structures 
were much smaller in size in the ATG9-knockout cells compared to ATG16L1-knockout cells, which might 
be due to presence of some residual autophagy in ATG9-knockout cells. Moreover, some ATG16L1-knockout 
cells had extremely large p62 structures associated with little LC3. However, the number of these cells in the 
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Figure 1. (a) Representative immunofluorescence images showing LC3 staining in ATG9 control and knockout 
cells. (b,c) Quantification of the LC3 puncta average size and average number from the images in (a) performed 
using ImageJ quantification tool (**p < 0.01, ***p < 0.001). Quantification performed from 3 experiments 
with >25 cells quantified for each condition. Error bars represent standard deviation (SD). (d) Representative 
images showing the rescue of the phenotype observed in ATG9-knockout cells using ATG9A-GFP construct. 
(e,f) Quantification of the LC3 puncta average size and average number from the images in (d) performed 
using ImageJ quantification tool (**p < 0.01, ***p < 0.001). Quantification performed from 3 experiments 
with >25 cells quantified for each condition. Error bars represent standard deviation (SD). (g) Representative 
immunofluorescence images showing LC3 staining in ATG16L1 control and knockout cells. ATG16 control and 
knockout cells were fixed with methanol and labelled for endogenous LC3. (h) Quantification of the average 
number of LC3 puncta as observed in the images shown in panel (g) performed using ImageJ quantification tool 
(**p < 0.01, ***p < 0.001). Quantification performed from 2 experiments with >25 cells quantified for each 
condition. Error bars represent standard deviation (SD). Scale bars represent a distance of 10 µm.
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population was very low (less than ~1% of the total population) (Fig. 5c). Our impression was that smaller p62 
structures appeared to have more LC3, compared to larger ones (Fig. 5b,c). These findings suggest that the LC3- 
and p62-positive structures present in autophagy-null cells may be aggregates.
To confirm that the p62 structures in autophagy-impaired cells are indeed aggregates, as they co-localised 
with ubiquitin, we performed a rapid detergent extraction of the membranes in ATG16L1-knockout cells trans-
fected with p62-pEGFP and RFP-LC3 (Fig. 6a and Supp. Fig. 5a,b). While the extraction results in the rapid loss 
of the RFP-LC3 signal within few seconds after addition of 1.5% Triton X-100, a significant fraction of RFP-LC3 
Figure 2. (a) Representative western blot showing the efficiency of ATG7 and ATG10 knockdown. (b) 
Representative western blot showing the decrease in LC3-II levels in cells upon ATG7 and ATG10 knockdown. 
(c) Quantification of the LC3-II levels with respect to levels of GAPDH upon depletion of ATG7 + 10 in HeLa 
cells. The statistical analysis was performed using one-tailed paired t-test. Error bars represent standard error 
of the mean (SEM). (d) Representative immunofluorescence images showing the morphology of LC3-positive 
structures under control and ATG7 + 10 knockdown conditions in HeLa cells. (e,f) Quantification of the LC3-
positive structures’ average total area and number under control and ATG7 + 10 knockdown conditions using 
ImageJ quantification tool (*p < 0.05). Quantification performed from 3 experiments with >20 cells quantified 
for each condition. Error bars represent standard deviation (SD). Scale bars represent a distance of 10 µm. Full-
length blots/gels are presented at the end of the Supplementary File.
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Figure 3. (a) Representative immunofluorescence images showing GFP-LC3G120A and early endosomal marker, 
EEA1 staining in ATG9 control and knockout cells. The graphs represent the quantification of LC3 puncta average 
size and average number in ATG9 control and knockout cells overexpressing GFP-LC3G120A using ImageJ 
quantification tool (**p < 0.01, ***p < 0.001). Quantification performed from 3 experiments with >25 cells 
quantified for each condition. Error bars represent standard deviation (SD). (b) Representative immunofluorescence 
images showing GFP-LC3G120A and early endosomal marker, EEA1, staining in ATG16L1 control and knockout 
cells. The graphs represent the quantification of LC3 puncta average size and average number in ATG16L1 control 
and knockout cells overexpressing GFP-LC3G120A using ImageJ quantification tool (*p < 0.05, **p < 0.01). 
Quantification performed from 3 experiments with >25 cells quantified for each condition. Error bars represent 
standard deviation (SD). (c) Representative immunofluorescence images showing Myc-LC3G120A-ΔC22 staining in 
ATG9, ATG16L1 control and knockout cells. The graphs represent the quantification of LC3 puncta average size and 
average number in these cells overexpressing Myc-LC3G120A-∆C22, using ImageJ quantification tool (*p < 0.05, 
**p < 0.01). Quantification performed from 2 experiments with >25 cells quantified for each condition. Error bars 
represent standard deviation (SD). Scale bars represent a distance of 10 µm.
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remains associated with p62-pEGFP positive structures (Fig. 6a, Supp. Fig. 5a,b). Moreover, upon separation of 
the cell lysates into soluble and insoluble fractions, LC3-I as well as p62 were observed to be associated with the 
insoluble fraction in ATG16L1-knockout cells (Fig. 6b). These findings demonstrate that LC3-I is sequestrated by 
p62 aggregates in autophagy-impaired cells.
p62 acts as a platform for LC3-I accumulation and is necessary for the formation of LC3-I pos-
itive structures in autophagy-deficient cells. We then tried to investigate whether the binding of LC3 
and p62 is required for the formation of these LC3-positive structures observed in autophagy-impaired cells. We 
first excluded the possibility that our results are due to increased binding between LC3 and p62 in ATG9- and 
ATG16L1-knockout cells by overexpressing GFP-LC3 and performing GFP-trap assays to pull-down GFP-LC3 
and probing for p62 levels. We observed no changes in the binding of LC3 to p62 in ATG9-knockout cells, 
whereas we found impaired binding in ATG16L1-knockout cells (Supp. Fig. 5c,d). The decrease in the LC3/p62 
interaction observed in ATG16L1-knockout cells could be due to increased p62 aggregation and precipitation in 
the insoluble fraction (Supp. Fig. 5c,d). We then expressed mutant forms of LC3, which are defective for p62 bind-
ing17,18. Our results showed that the average size and average number of LC3-positive structures in ATG9- and 
Figure 4. (a) Representative immunofluorescence images showing the co-localization of LC3-positive 
structures in autophagy-deficient ATG9 and ATG16L1 knockout cells with p62 using co-localisation profile 
generation. The co-localisation pixels for the image were identified, and a profile was generated using an 
unsupervised ImageJ plugin algorithm called colocalization, which was developed by Pierre Bourdoncle 
(Institut Jacques Monod, Service Imagerie, Paris; 2003–2004). (b) Representative immunofluorescence images 
showing the co-localization of p62 structures in autophagy-deficient ATG9 and ATG16L1 knockout cells with 
ubiquitin using co-localisation profile generation. The co-localisation pixels for the image were identified, 
and a profile was generated using an unsupervised ImageJ plugin algorithm called colocalization, which was 
developed by Pierre Bourdoncle (Institut Jacques Monod, Service Imagerie, Paris; 2003–2004). Scale bar 
represents a distance of 10 µm.
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ATG16L1-knockout cells expressing p62-binding defective mutant(s) was significantly decreased, compared 
to wildtype GFP-LC3 construct overexpression (Supp. Fig. 6a–d), demonstrating that LC3 and p62 binding is 
important for the formation of the aberrant LC3-positive structures observed in autophagy-impaired cells.
We then tested whether increased p62 levels were sufficient to cause the formation of prominent LC3-positive 
structures in autophagy-deficient cells by overexpressing a GFP-tagged version of p62 in ATG16L1 wildtype and 
knockout cells. The number and area of the LC3-positive structures increased remarkably upon p62 overexpres-
sion in the knockout but not in wildtype cells (Fig. 7a–c and Supp. Fig. 7a). The quantification of the size of these 
Figure 5. (a) Representative super-resolution immunofluorescence images showing the co-localization of LC3-
positive structures with p62 in ATG9 knockout cells. (b) Representative super-resolution immunofluorescence 
images showing the co-localization of LC3-positive structures with p62 aggregates in ATG16L1 knockout cells. 
(c) Representative super-resolution immunofluorescence images showing the co-localization of LC3-positive 
structures with larger p62 aggregates in ATG16L1 knockout cells. Scale bars have been labelled individually for 
each magnification.
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LC3-I positive structures was not statistically significant in p62-GFP overexpressed ATG16L1 knockout cells 
compared to control, due to formation of a high number of small p62 aggregates upon p62-GFP overexpression, 
which resulted in a large variance in size (Fig. 7d). Consistently, this difference could be clearly seen upon sorting 
the estimated sizes of LC3 puncta from representative ATG16L1-knockout cells overexpressing either empty-GFP 
or p62-GFP into equally-sized bins and depicting the frequency distribution in the form of a histogram (Fig. 7e). 
Consistent with our previous observations, we saw that overexpression of a p62 mutant defective for LC3-binding 
(via a mutation in LIR-domain)19 appeared to have a trend towards a decrease in the average size of LC3-positive 
structures in ATG16L1-knockout cells (Supp. Fig. 7b–d). Importantly, siRNA-mediated depletion of p62 (Supp. 
Fig. 8a,b) caused a clear reduction in the formation of LC3-positive structures in the autophagy-impaired cells, 
as measured by the average number and size of these LC3-I positive structures in ATG16L1-knockout cells, as 
well as in ATG9-knockout (Fig. 7f–h and Supp. Fig. 8c–e). Interestingly, siRNA-mediated depletion of p62 in 
ATG16L1-knockout cells also caused a significant reduction in LC3-I levels compared to control, suggesting that 
p62 impairs the degradation of LC3-I in autophagy-impaired cells (Supp. Fig. 8f,g). These experiments suggest 
that p62 acts as a platform for the formation of LC3-positive structures via its association with LC3-I in cells.
While larger LC3-positive structures have been seen by ourselves in autophagy-deficient HeLa cells, we also 
tested if this occurred in HepG2 cells. Our data showed that ATG7 + 10 knockdown decreased the number and 
size of LC3 structures (Supplementary Fig. 9). Thus, the phenomenon we have described may depend on cell-type 
and/or the extent to which autophagy is compromised.
Discussion
LC3 immunocytochemistry/immunohistochemistry/immunofluorescence is one of the most commonly 
used assays for measuring autophagosome number8. The technique is based on the principle that LC3-II is 
membrane-associated and thus appears as distinct puncta in the cell and can be easily visualised and hence quan-
tified1. Since LC3-II is regarded as a specific marker for autophagosomes, this assay can measure the number, size 
or area of the autophagosomes.
Figure 6. (a) Representative series of images depicting the live-cell imaging of cells during the detergent 
extraction experiment using 1.5% Triton X-100. ATG16L1-knockout cells expressing p62-pEGFP and RFP-LC3 
were subjected to rapid detergent extraction by addition of 1.5% Triton X-100. The cells were imaged in a time 
series every 15 seconds for 1½ minutes. (b) Representative western blot showing the presence of LC3-I as well as 
p62 in the insoluble fraction of ATG16L1-knockout cells. The blot also shows the lack of ATG16L1 expression 
in ATG16L1-CRISPR knockout cells and a corresponding increase in the p62 levels in these cells. Please refer to 
Supplementary Information File for full-length blots. Scale bars represent a distance of 20 µm.
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Figure 7. (a) Representative immunofluorescence images showing the morphology of LC3-I positive structures 
under control and p62-GFP overexpression conditions in ATG16 knockout cells. (b–d) Quantification of the LC3-
positive structures’ total area, average number and average size under control and p62 overexpression conditions 
using ImageJ quantification tool (*p < 0.05, ***p < 0.001, n.s = non-significant). Quantification performed from 3 
experiments with >25 cells quantified for each condition. Error bars represent standard deviation (SD). Scale bars 
represent a distance of 10 µm. (e) A histogram representing the frequency distribution of the estimated sizes of LC3 
puncta from representative ATG16L1-knockout cells expressing either empty-GFP or p62-GFP. The data was sorted 
into bin-size and bin-width of 0.50 µm2 and 0.05 µm2 respectively and a frequency distribution histogram was plotted 
using GraphPad Prism (version 5.01). (f) Representative immunofluorescence images showing the morphology 
of LC3-I positive structures under control and p62 knockdown conditions in ATG16L1 knockout cells. (g–h) 
Quantification of the LC3-positive structures’ average number and size under control and p62 knockdown conditions 
using ImageJ quantification tool (**p < 0.01, ***p < 0.001). Quantification performed from 3 experiments with >25 
cells quantified for each condition. Error bars represent standard deviation (SD).
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Our findings in this study, consistent with previous observations10–12, suggest major caveats with this assay 
at least in some commonly used cell types. In the absence of LC3-II formation (ATG16L1-knockout cells), or 
when LC3-II formation is impaired (ATG9-knockout cells), endogenous LC3-I (and probably LC3-II) can form 
puncta with p62, which accumulate when autophagy is impaired6,9. This phenomenon occurs even with par-
tial autophagy compromise after short-term knockdown of core autophagy genes. This can result in prominent 
LC3-positive structures, which may be confused with autophagosomes (Fig. 8). In some cases, one can see an 
increase of LC3-positive puncta when autophagosome formation is impaired, which was completely contrary 
to our expectations. This may be even more of an issue in in vivo experiments and has been shown to occur in 
ATG7-knockout mice9. Our data also suggest that one can get artefactual results if p62 expression levels are 
increased, or if p62 aggregation occurs when autophagy is perturbed6. It is also possible that the appearance of 
such LC3- and p62-positive aggregates may mirror a counteracting cellular pathway engaged in situations when 
autophagy is inhibited or impaired. For instance, LC3, which is also known to function in a form of phagocytosis 
(LC3-associated phagocytosis (LAP)20), may become functionally neutralised through p62 sequestration to avoid 
Figure 8. A schematic describing the process of LC3-I molecule sequestration by the p62 aggregates in 
autophagy-impaired and autophagy-null cells. The process of autophagy involves the lipidation of the cytosolic 
form of LC3 viz. LC3-I on to phosphotidylethanolamine (located on the growing phagophore) to form LC3-II, 
which is relatively specifically located on completed autophagosomes. The visualisation of LC3-II puncta 
using immunocytochemistry techniques is therefore considered to be a gold-standard assay to assess the 
autophagosome number in cells. Under conditions where autophagy is fully functional, LC3-I gets lipidated to 
form LC3-II, which results in the recruitment of ubiquitinated p62 attached to the cargo molecules destined 
for degradation. The p62-cargo complex is then engulfed into the growing autophagosomes and delivered 
to lysosomes for degradation. The LC3-II molecules then get delipidated/degraded to replenish the pool 
of cytosolic LC3-I in these cells. However, under conditions where LC3-I accumulates in cells as a result of 
autophagic impairment or complete abrogation, p62 aggregates (formed as a result of dysfunctional autophagy) 
sequester the excess LC3-I molecules forming structures that resemble autophagosomes. While these structures 
show an increased size compared to conventional autophagosomes, their presence might mislead an untrained 
eye, potentially resulting in confounding results. Please refer to the figure key for description of various 
symbols/structures.
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an imbalance in LAP under autophagy-impaired conditions. This could be a potential cellular response towards 
the stress imposed due to non-functional autophagy.
Also, while we only describe the involvement of p62 in this process, it is possible that some other auto-
phagy receptors might behave in a similar way under autophagy deficiency or if their total levels are increased. 
Nevertheless, p62 seems both necessary and sufficient for the accumulation of endogenous (this study) and over-
expressed (this study and12) LC3-I positive structures in autophagy-deficient conditions. While the appearance 
and number of LC3-positive structures in the presence of impaired autophagy is a concern, the extent to which 
this occurs and the numbers of these structures versus those seen in control cells may depend on the extent and 
period of autophagy inhibition and may be cell-type dependent. Importantly, the sequestration of LC3-I and 
likely LC3-II by p62 aggregates may also confound some other autophagy assays based on LC3 or LC3-family 
members such as GABARAP and GABARAP-L1.
Materials and Methods
Materials. The antibodies used in this study are: mouse anti-LC3B clone 5F10 (0231-100, NanoTools), rab-
bit anti-LC3B (EPR18709, Abcam), rabbit anti-LC3B for western blotting (NB100-2220, Novus biologicals) 
[Please note that the antibodies used against LC3 in this study specifically recognise only LC3B], mouse anti-p62 
(610832/3, BD Biosciences), rabbit anti-p62 (PM045, MBL), mouse anti-GFP (A6455, Invitrogen), rabbit anti-
RAB11 (715300, Invitrogen), mouse anti-EEA1 (ab70521, Abcam), rabbit anti-ATG9A (ab108338, Abcam), 
mouse anti-tubulin (T9026, Sigma), rabbit anti-ATG7 (ab52472, Abcam), rabbit anti-ATG10 (ab124711, Abcam), 
rabbit anti-ATG16L1 (D6D5, AB_10950320, Cell Signaling), rabbit anti-ATG16L1 (PM040, MBL), mouse anti-
GAPDH (ab2107448, Abcam) and all the Alexa-conjugated secondary antibodies were purchased from Invitrogen. 
The pEGFP-LC3, pEGFP-LC3-G120A and RFP-LC3 constructs were kind gifts from Dr. T. Yoshimori (Osaka 
University, Japan). ATG9A-pEGFP was a kind gift from Dr Y. Takahashi (Penn State College of Medicine, USA), 
C1-mCherry was from Clontech (632524), mCherry-p62 and mCherry-p62 LIR mutant (DDDW335-338AAAA) 
was a kind gift from Dr. Sascha Martens (University of Vienna, Austria), p62-pEGFP was a kind gift from Dr. 
Terje Johansen (Artic University, Norway), while Myc-LC3-G120A-ΔC22 was a gift from Dr. T. Yoshimori 
(Addgene plasmid # 45449). The pSpCas9(BB)-2A-Puro (PX459) V2.0 was a gift from Dr. F. Zhang (Addgene 
plasmid # 62988). pCMV-ATG7 was a kind gift from Dr. Isei Tanida. EGFP-LC3K51A and EGFP-LC3F52A were 
created by site mutagenesis using the Q5 Site-Directed Mutagenesis kit (NEB E0554S) and pEGFP-LC3 as a tem-
plate according to the manufacturer’s instructions. Primers used for the K51A mutation: 5′-ccgtcctggacaagaccg-
cgttccttgtacctgatc-3′ and for the F52A mutation: 5′-gtcctggacaagaccaaggcccttgtacctgatcacgt-3′. For creating the 
GFP-GABARAP-GA and GFP-GABARAPL1-GA we first generated GFP-GABARAP and GFP-GABARAPL1 by 
cloning the respective coding sequences (ordered from GeneScript) onto the pEGFP-C1 backbone (Clontech). 
Primer sequences used for GFP-GABARAP: 5′-CCCGAATTCCATGAAGTTCGTGTACAAAGA-3′ and 
5′-CCCGGAT CCTCACAGACCGTAGACACTTTC-3′, for GFP-GABARAPL1: 5′-CCCGAATTCC 
ATGAAGTTCCAGTACAAGGA-3′ and 5′-CCCGGATCCTCATTTCCCATAGACAC TCTC-3′. The lipidation 
deficient mutants were made by introducing G116A (for GABARAP) and G142A (for GABARAPL1) mutations 
using the Q5 Site-Directed Mutagenesis kit (NEB E0554S) according to the manufacturer’s instructions. For GFP-
GABARAP-G116A primers used were: 5′-AGTGTCTACGcTCTGTGAGGATC-3′ and 5′-TTCGTCACTGTAGG 
CAATG-3′. For GFP-GABARAPL1-G142A primers used were: 5′-CTTACATATGcCAGTGTAAGGC-3′ and 
5′-AGGATCCGGATAAATAAC-3′.
Cell culture. HeLa cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 
10% v/v fetal bovine serum, 100 U/ml penicillin-streptomycin and 2 mM L-glutamine. HepG2 cells were main-
tained in RPMI 1640 medium supplemented with 10% v/v fetal bovine serum, 100 U/ml penicillin-streptomycin, 
all obtained from Sigma, UK. The cell lines were maintained by passaging the cells, using Trypsin-EDTA solution 
(Sigma), after they are sub-confluent to around 75–90% in T75 (75 cm2 area) flasks (Falcon). The cell line used for 
this study was HeLa (Human cervical cancer cells) cell line. In experiments where we needed to block autophagic 
flux, cells were treated with 400 nM of bafilomycin A1 for 4 hours at 37 °C.
Transfection. The HeLa cells were transfected with the purified plasmid using the Mirus TransIT-2020 trans-
fection reagent. The transfection was performed using optiMEM medium, using the manufacturer’s protocol. 
Briefly, a mixture of 100 μl of optiMEM with 1 μg of DNA was prepared and incubated at room temperature for 
5 minutes. Another mixture containing 100 μl optiMEM with 5 μl of Mirus was prepared and incubated for 5 min-
utes. Both of the solutions were then mixed together and incubated for approximately 20–25 minutes. The total 
volume was then added to one well of a 6-well plate, already containing 1 ml of optiMEM. The amount of DNA 
generally used for transfection was 1 μg for a 6-well.
siRNA-mediated knockdown. The cells for siRNA knockdown were transfected using lipofectamine 2000 
transfection reagent. The transfection was performed using optiMEM medium, using the manufacturer’s pro-
tocol. Briefly, a mixture of 100 μl of optiMEM with 3 μl of 20 μM or 1 μl of 100 μM siRNA was prepared and 
incubated at room temperature for 5 minutes. Simultaneously, another mixture containing 100 μl optiMEM 
with 5 μl of Lipofectamine 2000 was prepared and incubated for 5 minutes. Both the solutions were then mixed 
together and incubated for approximately 20–25 minutes. The total volume was then added to one well of a 6-well 
plate, already containing 1 ml of optiMEM for 4 hours at 37 °C. After the incubation, the media was changed and 
replaced with full media. The cells were then harvested after 48 hours of incubation if a single knockdown (KD) 
was desired, as for the ATG7 and ATG10 KD in HeLa cells. For the ATG7 and ATG10 rescue experiments, a 
pcDNA.3 (empty vector) or ATG7 plus ATG10-FLAG were used to transfect cells 24hrs after the siRNA transfec-
tion. For double KD studies, we performed another round of siRNA transfection, following the same protocol as 
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mentioned above, after the first round (for p62 KD studies). For siRNA knockdown in HepG2 cells, these were 
transfected using Lipofectamine RNAi max transfection reagent using 100 nM final siRNA and two rounds of 
siRNA transfection were performed to achieve an efficient knockdown. Cells were then split and seeded to respec-
tive plates or coverslips for further experiments. The scrambled siRNA (ON-TARGETplus Non-targeting Pool, 
D-001810-10), human ON-TARGETplus SQSTM1 (SMARTpool, L-010230-00-0005), human ON-TARGETplus 
ATG7 (SMARTpool, L-020112-00), human ON-TARGETplus ATG10 (SMARTpool, L-019426-01) were ordered 
from Dharmacon and used at a final concentration of 50–100 nM.
GFP-trap assays. HeLa cells were transfected with EGFP-LC3 using Mirus TransIT-2020 transfection 
reagent and 24hrs later were lysed in lysis buffer (50 mM HEPES, 150 mM NaCl, 1% Triton X-100, 1.5 mM 
MgCl2, 5 mM EGTA) for 10 min on ice and pelleted for 10 min at 13,000 rpm. GFP-tagged proteins (EGFP or 
EGFP-LC3) were pulled down using GFP-TRAP beads (ChromoTek), according to the manufacturer’s protocol. 
Immunoprecipitates were eluted by boiling the samples in Laemmli buffer for 5 min. Proteins were resolved by 
SDS-PAGE.
Immunofluorescence. The immunocytochemistry was performed on cells grown on 22 × 22 mm cover-
slips. HeLa cells were grown at a confluency of 70–80%, washed once with PBS and then fixed either using 4% 
w/v PFA for 5–7 minutes or cold-methanol for 3–5 minutes at 4 °C. Please note that since most of the antibodies 
used in the study worked only upon PFA fixation, the samples were generally fixed with 4% w/v PFA in PBS 
unless otherwise mentioned in the figure legend(s). PFA was discarded in accordance with the safety regulations 
and the cells were washed thrice with PBS. The cells were then permeabilised using 0.5% v/v Triton X-100 for 
5–7 minutes and washed three times with PBS to remove any residual detergent. A solution containing 1% w/v 
BSA was then added onto the coverslips, as a blocking solution, to reduce the non-specific binding of the primary 
and secondary antibodies, and kept for 1 hour at room temperature. The blocking solution was then tapped off 
the coverslips and the primary antibodies at appropriate dilutions were added on the coverslips. The coverslips 
with primary antibodies were incubated at 4 °C for 16–20 hours in a moist and humid chamber. The covers-
lips were next washed three times with PBS and incubated with a solution containing secondary antibodies for 
1 hour at room temperature. (Note that the primary and secondary antibody solutions were made in the blocking 
buffer.) The dilution of the secondary antibodies used for this study was 1:400 prepared in 1% w/v BSA solution. 
Finally, coverslips were washed twice with PBS and high purity sterile water and mounted on glass slides using 
Pro-Long gold anti-fade DAPI mounting medium (Invitrogen, US). The coverslips were then imaged using the 
Zeiss LSM880 or LSM780 confocal microscope using the 63x oil immersion objective.
Live-cell imaging. ATG16L1-knockout cells were seeded on to the MatTek dishes (MatTek, Ashland MA 
USA). The following day, these cells were transfected with appropriate plasmid based on experimental require-
ments using Mirus Trans-IT 2020 transfection reagent. The transfection was performed using optiMEM medium, 
using the manufacturer’s protocol. A 2% Triton X-100 stock solution was then used to reach the designated con-
centration for detergent extraction of the plasma membrane. A final concentration of 1% Triton X-100 is capable 
of extracting the cytosolic and membrane bound. The experiment to confirm the presence of p62 aggregates in 
ATG16L1-knockout cells, however, involved detergent extraction using 1.5% Triton X-100 as the final concentra-
tion to subject the cells to harsher conditions of extraction. Imaging then was performed using the ‘Time series’ 
module on an incubated Zeiss AxioObserver Z1 microscope with a LSM780 confocal microscope using a 63 × 1.4 
NA Plan Apochromat oil-immersion lens.
Super-resolution microscopy. Samples were seeded onto Zeiss High precision No 1.5 170+ or −5 μm, 
18 mm × 18 mm coverslips. Following staining, the samples were mounted in Pro-Long gold anti-fade DAPI mounting 
medium (Life Technologies) and left to harden for 3 days to reach a constant Refractive Index (RI) of 1.46. Samples were 
imaged using Structured Illumination on the Elyra PS1 (Carl Zeiss Microscopy). Following stage alignment, laser lines 
of 405, 488 and 561 nm were used to image a bead stack in order to correct for chromatic aberration using the channel 
alignment algorithm. Z-stacks were acquired at 5 phases and 5 rotations of the illumination grid and subsequently 
processed and aligned using the ZEN Black Elyra edition software (Carl Zeiss Microscopy).
Extraction of soluble and insoluble fractions. The extraction of the soluble and insoluble fractions from 
ATG16L1-knockout cells was performed in RIPA buffer. Briefly, the cells were washed with 1X ice-cold PBS once 
and were scraped, lysed in 500 µl of RIPA buffer and collected in labelled tubes kept on ice. The composition of 
RIPA buffer was as follows –
RIPA buffer






At the time of use, RIPA buffer was supplemented with cOmplete protease inhibitor tablet (1 tablet per 50 ml) 
and phosphatase inhibitor cocktails 2 and 3 (1:100 each).
The lysates were then passed through a 25 G needle 10 times and then the solution was centrifuged at 
14000 rpm for 15 minutes at 4 °C. After centrifugation, the supernatant was collected in a fresh Eppendorf tube 
and was labelled as the soluble fraction and was mixed with 300 µl of 2X Laemmli buffer and was boiled for 5 min-
utes. The pellet obtained after centrifugation consists of the insoluble fraction and was resuspended and washed 
13Scientific RepoRts |         (2019) 9:10147  | https://doi.org/10.1038/s41598-019-46657-z
www.nature.com/scientificreportswww.nature.com/scientificreports/
with 500 µl of RIPA buffer. The resuspended solution was then centrifuged at 14000 rpm for 5 minutes at 4 °C. 
The supernatant was discarded and the pellet was resuspended in 100 µl of UREA + RIPA buffer. This was finally 
mixed with 100 µl of 2X Laemmli buffer and was boiled for 5 minutes. The composition of UREA + RIPA buffer 
consists of additional Urea at a final concentration of 2 M together with the components of RIPA buffer.
Western blot. Cells cultured in 6-well plates were lysed and collected in 2X Laemmli buffer (4% w/v SDS, 
20% v/v glycerol, 10% v/v 2-mercaptoethanol, 0.004% w/v bromophenol blue and 125 mM Tris HCl, pH 6.8). 
After the cells were lysed, 20–30 μl of the samples were loaded onto a 10-well, 12–15% SDS-PAGE and run at 
100–120 V. A standard M.W. ladder was loaded along with the samples to keep a track of the movement of the 
proteins in the gel. The proteins were then transferred onto the activated PVDF at 100 V for 60 minutes. The mem-
brane was removed on completion of the transfer and was soaked in 5% w/v skimmed milk to block non-specific 
binding sites, for 1 hour at room temperature. Next, a solution containing specific primary antibody (prepared 
in 5% w/v skimmed milk) at an appropriate dilution was added on to the membrane for overnight incubation 
at 4 °C. The membranes were then washed three times with PBST (Phosphate buffer saline +0.1% Tween-20) 
before the addition of secondary antibody. The secondary antibody, also prepared in 5% w/v skimmed milk, was 
incubated with the membrane for 1 hour at room temperature. The dilution of the secondary antibody was gen-
erally kept at 1:4000 for enhanced chemiluminescence (ECL) HRP-conjugated antibodies and 1:5000 for LICOR 
fluorophore-conjugated antibodies. The membranes were then washed again with PBST multiple times and devel-
oped using a mixture of equal volumes of developing solutions 1 and 2 for ECL or imaged directly for fluorescence 
signal detection using LICOR Image Studio software (LICOR, US).
CRISPR knockout cell generation. The guide RNAs were designed for the generation of ATG9 knockout 
cells using the online tool developed by the Zhang Lab21. The top three single guide RNA (sgRNA) hits were 
modified manually to add BbsI restriction sites and these sgRNA sequences of desalted purity were ordered from 
Invitrogen. The sequence successfully used for ATG9 CRISPR knockout was:
The highlighted nucleotides indicate the added overhangs. The sgRNA was then ligated in the 
psCas9-2A-puromycin backbone. The successfully ligated plasmids or empty Cas9 vector control were then 
transfected in HeLa cells and the expression was allowed for 24 hours. Transfected cells were then selected by 
adding puromycin to the cells at a final concentration of 2–4 µg/ml. Cells were allowed to grow until all the 
non-transfected cells were dead. The positive cells were then trypsinised and the cell number was assessed using 
Invitrogen Countess slides (10 µl homogenous cell suspension +10 µl Trypan blue). Based on the live cell popu-
lation, 0.2 × 104 cells were aspirated and serially diluted in a 96-well plate to obtain single cell colonies. The serial 
dilution was always 1:1 and the final volume in each well at the end of dilution was kept to 200 µl. The cell lysates 
were then loaded on SDS-PAGE, transferred to a membrane to check for the knock-out of ATG9.
Quantification of data and Statistical analysis. The images were quantified using the default ‘Analyze 
particles’ plugin in ImageJ. Additionally, the co-localised pixels were identified, and a profile was generated using 
an unsupervised ImageJ plugin algorithm called ‘colocalization’, which was developed by Pierre Bourdoncle 
(Institut Jacques Monod, Service Imagerie, Paris; 2003–2004). The western blots were quantified using the LICOR 
Image Studio software (LICOR, US) and the values were processed, analysed and plotted using Excel program 
from the Microsoft Office suite.
The statistical significance levels for comparisons between two groups were estimated using one-tailed or 
two-tailed t-tests. For the experiment involving ATG7 and ATG10 KD, one-tailed t-test was used to assess the 
statistical significance of the data. For all the other experiments in this study, a two-tailed t-test was used to assess 
the statistical significance of the data. In this paper, the value of p < 0.05 was considered statistically significant 
and the conventions used to depict the results across this article are as follows: *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001 
and Error bars represent standard deviations unless otherwise mentioned.
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